Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children

  • STATUS
    Recruiting
  • participants needed
    20
  • sponsor
    IRCCS Eugenio Medea
Send
Updated on 19 February 2024
See if I qualify
psychiatric disorder
deficit
psychiatric disorders
methylphenidate
attention deficit hyperactivity disorder
hyperactivity
attention deficit disorder

Summary

MIMOSA study aims to characterize from behavioral, neurophysiological and neurocognitive perspectives children and adolescents with attention deficit hyperactivity disorder (ADHD), in order to identify a possible biomarker of response to medication treatments. To achieve this aim, in the study children with ADHD (drug naive) are recruited and undergo behavioral and clinical screenings, neurocognitive profile, and neurophysiological evaluation with functional near infrared spectroscopy (fNIRS). ADHD group is evaluated before the beginning of medications, at first dose of medication (only imaging evaluation fNIRS), and after a period of two/three months of continuous treatment with medication.

Details
Condition Oppositional Defiant Disorder, Attention deficit hyperactivity disorder
Age 6years - 18years
Treatment Methylphenidate
Clinical Study IdentifierNCT04272021
SponsorIRCCS Eugenio Medea
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

diagnosis of ADHD according to DSM-5 (Diagnostic and Statistical Manual of Mental Disorders-5) criteria
drug naive

Exclusion Criteria

presence of intellectual disability, neurological diseases, epilepsy, genetic syndromes
and previous treatment with psychoactive drugs
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

psychiatric disorder
deficit
psychiatric disorders
methylphenidate
attention deficit hyperactivity disorder
hyperactivity
attention deficit disorder

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.